Conditions We Treat · Bergen County, NJ
Conditions We Treat at Valley Spring Recovery Center
Valley Spring Recovery Center treats substance use disorders across four levels of outpatient care — Partial Care, IOP, Outpatient, and Virtual — for adults 18+ in Bergen County, NJ. CARF-accredited, dual NJ licensed, in-network with 17 major insurers.
12
Substance Conditions Treated
17+
Insurance Plans Accepted
8:1
Staff-to-Patient Ratio
24/7
Admissions Available
All Conditions
Substance-Specific Addiction Conditions We Treat
Each condition page includes program options, signs of addiction, treatment process, insurance information, and FAQs specific to that substance.
Alcohol Addiction
PC, IOP, and outpatient alcohol rehab with medical detox referral, MAT (Naltrexone, Vivitrol), CBT, and relapse prevention. Most insurance accepted.
View treatment options High DemandHeroin Addiction
Evidence-based heroin addiction treatment with Suboxone, Brixadi, and Vivitrol for opioid use disorder alongside individual and group therapy.
View treatment optionsOpioid Addiction
Comprehensive opioid use disorder treatment including medication-assisted treatment (MAT), EMDR, trauma-informed care, and case management.
View treatment optionsFentanyl Addiction
Fentanyl addiction recovery with on-site psychiatric medication management, Suboxone induction, and intensive group and individual therapy.
View treatment optionsCocaine Addiction
Stimulant use disorder treatment with CBT, DBT, motivational interviewing, and psychiatric evaluation within 24 hours of admission.
View treatment optionsBenzodiazepine Addiction
Safe benzo dependence treatment with detox referral coordination, taper management, and dual diagnosis support for co-occurring anxiety disorders.
View treatment optionsMethamphetamine Addiction
Meth addiction treatment addressing co-occurring psychosis, depression, and anxiety alongside evidence-based behavioral therapies and wellness programming.
View treatment optionsMarijuana Addiction
Cannabis use disorder treatment with motivational interviewing, CBT, and co-occurring mental health support for anxiety and depression.
View treatment optionsPrescription Drug Addiction
Prescription drug addiction recovery including opioid painkillers, stimulants, and sedatives, with FMLA coordination and employer documentation.
View treatment optionsAdderall Addiction
Stimulant use disorder treatment for Adderall and prescription amphetamine misuse, with psychiatric evaluation and ADHD dual diagnosis support.
View treatment optionsMDMA Addiction
MDMA and ecstasy addiction treatment addressing neurotoxicity effects, depression, and anxiety with evidence-based behavioral and psychiatric care.
View treatment optionsXanax Addiction
Xanax (alprazolam) dependence treatment with medical detox referral, co-occurring anxiety disorder management, and taper-supported recovery planning.
View treatment optionsDetox Requirements
Withdrawal Severity and Medical Detox by Substance
Some substances produce dangerous, medically supervised withdrawal (alcohol, benzodiazepines, opioids). Others produce uncomfortable but non-life-threatening withdrawal (cocaine, meth, cannabis, stimulants). Knowing which category your substance falls into determines whether you start with medical detox or directly with outpatient programming.
| Substance | Withdrawal Severity | Medical Detox Required? | Clinical Detail |
|---|---|---|---|
| Alcohol | SEVERE | Yes — detox first | Alcohol withdrawal can include seizures and delirium tremens (DTs). Medically supervised detox is required for moderate-to-heavy daily users. |
| Heroin / Opioids | MODERATE–SEVERE | Yes — detox first | Opioid withdrawal is rarely fatal but severely uncomfortable. Medical detox with Suboxone induction is the standard of care. |
| Fentanyl | SEVERE | Yes — detox first | Fentanyl withdrawal onset is faster and more intense than heroin. Medical detox with careful Suboxone titration is essential. |
| Benzodiazepines | SEVERE | Yes — detox first | Benzodiazepine withdrawal can be fatal — seizures, delirium, and rebound anxiety. Medical taper, not cold-turkey cessation, is required. |
| Xanax (alprazolam) | SEVERE | Yes — detox first | Same withdrawal profile as benzodiazepines generally. Medical taper required; abrupt cessation can cause seizures. |
| Cocaine | MODERATE | Outpatient OK | Cocaine withdrawal is psychological (depression, fatigue, cravings) rather than medically dangerous. Outpatient treatment usually begins directly. |
| Methamphetamine | MODERATE | Outpatient OK | Meth withdrawal involves severe depression, sleep dysregulation, and anhedonia, but is not medically dangerous. Outpatient PC often appropriate as first step. |
| Marijuana | MILD | Outpatient OK | Cannabis withdrawal includes irritability, sleep disturbance, and craving. No medical detox needed; outpatient programming is the standard. |
| Prescription opioids | MODERATE–SEVERE | Yes — detox first | Same withdrawal profile as illicit opioids. Medical detox plus MAT induction are standard, especially for high-dose chronic use. |
| Adderall (stimulant) | MILD–MODERATE | Outpatient OK | Stimulant withdrawal: fatigue, depression, sleep disturbance. Not medically dangerous; outpatient treatment begins directly. |
| MDMA | MILD–MODERATE | Outpatient OK | Post-MDMA depression and serotonin dysregulation can persist for days to weeks. Outpatient treatment with psychiatric support is standard. |
| Prescription stimulants / sedatives | VARIES | Outpatient OK | Depends on the specific medication and dose. Clinical assessment determines whether medical taper is needed. |
Severity ratings are general guidance. Individual clinical evaluation determines whether detox is required for any specific client. Valley Spring coordinates direct referral to detox partners when medically necessary, then re-engages clients at PC immediately afterward.
Medication-Assisted Treatment
FDA-Approved MAT Availability by Substance
Medication-Assisted Treatment is FDA-approved for opioid and alcohol use disorders. For stimulants, cannabis, and benzodiazepines, FDA-approved maintenance MAT does not exist — behavioral therapy is the evidence-based primary intervention, with psychiatric medication addressing co-occurring symptoms.
Alcohol Use Disorder
Medications
- ●Naltrexone (oral)
- ●Vivitrol (IM, monthly)
- ●Acamprosate
Naltrexone and Vivitrol reduce cravings and block reinforcement; acamprosate reduces post-acute withdrawal.
Opioid Use Disorder
Medications
- ●Suboxone (buprenorphine/naloxone)
- ●Brixadi (extended-release buprenorphine)
- ●Vivitrol (naltrexone IM)
- ●Sublocade
Buprenorphine products are first-line. Naltrexone IM is an option after detox.
Cocaine / Stimulant Use Disorder
Medications
- ●No FDA-approved MAT
- ●Off-label: Topamax, modafinil, bupropion (case-by-case)
Behavioral therapies (contingency management, CBT) are the evidence-based primary intervention.
Methamphetamine Use Disorder
Medications
- ●No FDA-approved MAT
- ●Off-label: bupropion + naltrexone combination (emerging research)
Behavioral therapy is the primary intervention; psychiatric medication addresses co-occurring symptoms.
Benzodiazepine Use Disorder
Medications
- ●Medical taper (not maintenance MAT)
- ●Gabapentin or pregabalin (adjunct, off-label)
Slow medical taper is standard. There is no maintenance MAT analogous to Suboxone for benzos.
Cannabis Use Disorder
Medications
- ●No FDA-approved MAT
- ●Off-label: N-acetylcysteine (emerging adolescent evidence)
Behavioral therapies are primary. Psychiatric medication addresses co-occurring anxiety or depression.
Valley Spring delivers MAT on-site via its psychiatric team across PC, IOP, and outpatient. Learn more on the Medication-Assisted Treatment program page.
Co-Occurring Mental Health
Common Co-Occurring Mental Health Patterns by Substance
Most substance use disorders co-occur with at least one mental health condition. Recognizing the pattern early lets the clinical team plan integrated dual-diagnosis treatment from day one rather than treating each condition in sequence.
| Substance | Primary Co-Occurring Condition | Secondary Co-Occurring | Clinical Pattern |
|---|---|---|---|
| Alcohol | Depression | Anxiety, trauma | Self-medication of low mood; alcohol use deepens depression over time. |
| Opioids | PTSD | Depression, chronic pain | Opioids numb trauma-related hyperarousal; withdrawal reactivates trauma symptoms. |
| Cocaine | ADHD | Bipolar disorder, anxiety | Stimulant use sometimes self-medicates undiagnosed ADHD; can trigger or extend manic episodes in bipolar. |
| Benzodiazepines | Anxiety disorders | PTSD, insomnia | Benzos prescribed for anxiety lead to dependence; discontinuation rebounds anxiety severely. |
| Methamphetamine | ADHD | Depression, psychosis | Self-medication of ADHD or depression; chronic use can induce stimulant psychosis. |
| Cannabis | Anxiety | Depression, psychotic disorders (in vulnerable individuals) | Initial anxiety relief gives way to rebound anxiety; in vulnerable users, can precipitate psychotic symptoms. |
Levels of Care
How Each Substance Addiction Is Treated at Valley Spring
Regardless of the substance, every client enters an individualized treatment plan across one or more levels of outpatient care under the RAAT model, with no facility transfers between levels.
What Every Condition Gets
- Biopsychosocial assessment within first 24 hours
- Psychiatric evaluation and medication management on-site
- Individual therapy 1–2× per week
- Substance-specific group therapy and psychoeducation
- FMLA, legal, and employer documentation support
- Family therapy and Together We Heal family workshop
- Case management and discharge planning
- Thrive alumni program, lifelong recovery support
Find Treatment for Your Condition Today
Call Valley Spring Recovery Center 24/7. Same-day admissions. CARF-accredited, NJ dual-licensed, 17 insurance plans accepted.
HIPAA compliant · Confidential · No obligation
Why Choose Valley Spring
What Makes Valley Spring Different for Substance Use Treatment?
Dual NJ State Licensed
SUD #200887 and MH #70420104, treating substance addiction and co-occurring mental health simultaneously in one integrated program.
8:1 Maximum Staff-to-Patient Ratio
Groups capped at under 10 patients. More individualized attention per client than most outpatient programs in New Jersey.
On-Site Psychiatric Medication Management
MAT including Suboxone, Vivitrol, Brixadi, and Naltrexone, plus psychiatric medications for co-occurring conditions. All managed on-site.
Same-Day Admissions Available
Pre-screening, insurance verification, and clinical approval completed within one hour. Same-day or next-day intake when criteria are met.
CARF Accredited & BBB A+
CARF International accreditation and Better Business Bureau A+ rating, independently verified clinical quality and business integrity.
In-Network with 17 Major Insurers
Horizon, Aetna, Cigna, United Healthcare, NYSHIP, Tricare, Magellan, AmeriHealth, Oscar, and more. Most clients pay only their copay or deductible.
FAQ
Frequently Asked Questions About Conditions We Treat
Does Valley Spring treat all types of substance addictions?+
Yes. Valley Spring treats alcohol, heroin, opioids, fentanyl, cocaine, benzodiazepines, methamphetamine, marijuana, prescription drugs, Adderall, MDMA, and Xanax. Each substance-specific program includes individualized treatment planning, psychiatric evaluation, and case management.
What is the difference between addiction conditions and addiction programs?+
Addiction conditions refer to the specific substance being treated, such as alcohol, opioids, or cocaine. Addiction programs refer to the level of care and structure of treatment, such as Partial Care (PC), Intensive Outpatient (IOP), or Outpatient. Every condition is treated across all program levels at Valley Spring.
Do I need a referral to start substance-specific addiction treatment?+
No referral is required. Call Valley Spring's admissions line at (855) 924-5320 to begin a free clinical pre-screening. Most admissions are confirmed within one hour. Same-day intake is available when clinical and insurance criteria are met.
Does insurance cover substance-specific addiction treatment at Valley Spring?+
Valley Spring is in-network with 17 major insurance contracts, including Horizon Blue Cross, Aetna, Cigna, United Healthcare, NYSHIP, Tricare, Magellan, and more. Most clients pay only their copay, coinsurance, or deductible. Insurance verification is completed during pre-admission at no cost.
Can co-occurring mental health conditions be treated alongside addiction?+
Yes. Valley Spring is dual-licensed by the State of New Jersey for both substance use disorder (SUD #200887) and mental health (MH #70420104). Co-occurring conditions, including anxiety, depression, PTSD, bipolar disorder, and OCD, are treated simultaneously within the same program.
What medications does Valley Spring use for addiction treatment?+
Valley Spring offers on-site medication-assisted treatment (MAT) including Suboxone, Vivitrol, Brixadi, Naltrexone, Topamax, and the full buprenorphine range. Psychiatric medications for co-occurring conditions are also managed on-site by the psychiatry team.
Ready to Start Treatment?
Call (855) 924-5320, available 24/7. Free insurance verification. Same-day admissions available.
HIPAA compliant · Confidential · No obligation